7 March 2020 in Mediators of Inflammation
Background. Recent studies suggest that leptin is involved in Th2 response in allergic rhinitis (AR). However, the effect of leptin on type II innate lymphoid cells (ILC2s) in AR is not well characterized.Methods. Twenty-six AR patients and 20 healthy controls were enrolled. Serum leptin levels were measured, and their correlation with ILC2 and type II cytokines were analyzed using enzyme-linked immunosorbent assay (ELISA) and flow cytometry. ILC2 differentiation and cytokine production stimulated by human recombinant leptin were analyzed by real-time polymerase chain reaction (PCR) and ELISA. AR mouse models were also established to verify the effect of leptin on ILC2 cell regulation.Results. Our results showed that elevated serum leptin in AR patients was correlated with the percentage of ILC2 and the expression of type II cytokines. The recombinant leptin enhanced the expression of ILC2 cell transcription factors and type II cytokine through the PI3K/AKT pathway. The AR mice treated with leptin showed as stronger ILC2 inflammation and symptoms compared with control mice.Conclusions. Our data provide evidence that upregulation of leptin promotes ILC2 responses in AR and this process was achieved through the PI3K/AKT pathway.
1 January 2020 in Journal of Immunology Research
Objectives . Interleukin‐27 (IL‐27) has been reported to inhibit type 2 T helper cell (Th2) response in allergic rhinitis (AR). However, its effects on group II innate lymphoid cells (ILC2) in AR are not fully understood. Methods . Nineteen patients with AR and nineteen controls were enrolled in this study. The effects of IL‐27 on ILC2 differentiation and function as well as the regulation of the IL‐27 receptor (IL‐27R) were analyzed by tritiated thymidine incorporation, enzyme‐linked immunosorbent assay (ELISA), and real‐time polymerase chain reaction (PCR), respectively. AR mice were used to confirm the role of IL‐27 in vivo . Results . The serum IL‐27 protein expression in AR patients was significantly lower compared with controls. IL‐27 decreased the ILC2 proliferation and type II cytokine secretion through the interaction with IL‐27R. IL‐27 also inhibited systemic and nasal ILC2 response of AR mice. Conclusion . IL‐27 inhibited the proliferation and function of ILC2 in AR, implying that IL‐27 may be used as new treatment target in AR.
16 January 2025 in Mediators of Inflammation
Background: Although numerous studies have focused on diagnostic biomarkers to help identify allergic rhinitis (AR), data on the characteristics of pediatric AR with different severity is limited. We aimed to compare the characteristics of pediatric AR with different severity. Methods: A total of 1054 children with AR were enrolled and classified into mild intermittent AR, mild persistent AR, moderate‐to‐severe intermittent AR, and moderate‐to‐severe persistent AR. All children were surveyed using a questionnaire that included detailed demographic information. Blood cell analysis was performed using an automatic hematology analyzer. Results: No significant differences were observed in feeding patterns, dietary habits, outdoor activity time, total IgE, eosinophil count, and eosinophil percentage among the different AR subgroups. However, a higher prevalence of a family history of AR was noted in the moderate‐to‐severe persistent group. Symptoms were more likely to exacerbate when using air conditioning in children with moderate‐to‐severe persistent AR. Multivariate regression analysis also showed that symptom exacerbation when using air conditioning was associated with disease severity. Conclusions: This study suggests that exacerbation of symptoms during air conditioning use can be considered a predictive factor for the severity of pediatric AR. Doctors and parents should pay special attention to these children to prevent more severe symptoms and improve the quality of life of these patients as early as possible.